Analyst consensus rating
Tenax Therapeutics Analyst Rating: none
TENX is rated none by 10 analysts with a $11.70 target. As of 2026-08-27.
Direct answer
Tenax Therapeutics's consensus rating is none.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $11.70.
Forecast evidence checked August 27, 2026.
Get free Tenax Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.12
- Average price target
- $11.70
- High price target
- $36.00
- Low price target
- $4.00
- Low target gap
- +88.7%
- Target upside
- +451.9%
- High target gap
- +1,598.1%
- Target range width
- 1,509.4%
- Consensus rating
- none
- Analysts
- 10
- Evidence date
- August 27, 2026
- Valid through
- September 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tenax Therapeutics?
Tenax Therapeutics has a verified none consensus. The same dataset has an average price target of $11.70.
How far are Tenax Therapeutics's low and high targets from the recorded price?
The low target implies +88.7%, while the high target implies +1,598.1%.
How many analysts are included in Tenax Therapeutics's consensus?
The verified consensus includes 10 analysts.
How is Tenax Therapeutics's target upside or downside calculated?
The average target of $11.70 is divided by the recorded price of $2.12, then one is subtracted to produce +451.9%. This does not guarantee a future return.
When was Tenax Therapeutics's analyst forecast verified?
The data was verified on 2026-08-27. The dataset is valid through 2026-09-03.